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, where s p 2 and s N 2 are the analyte variances for the positive and negative distributions, respectively), sample sizes sufficient to test the requirements that a given method detects ³90% of the positives (³5 ppm of a given analyte) while misclassifying £10% of the negatives (implying a specificity rate, true negatives that will be correctly classified, of 90%) were estimated by using a rationale that minimizes the cost of sampling.
I n designing a validation scheme for screening tests used for allergen detection, we had to determine the amount of analytical work that would be necessary to validate a method as having predefined performance specifications. We decided that the sample size should provide ³80% confidence, when a screening method that generates quantitative data is tested, to verify that the method has a sensitivity rate of 90% for positive samples (samples containing ³5 ppm analyte) and a false positive rate of 10% for negative samples (samples free of analyte).
The problem as stated defined the required sensitivity rate (P + = true positives, samples at levels of ³5 ppm, that will be correctly classified by the method) and false positive rate (pf + = true negatives, samples at levels of <5 ppm, that will be misclassified as positive by the method). Therefore, in accomplishing the objective, sample sizes sufficient to test the requirements that the method detects ³90% of the positives (³5 ppm of a given analyte) while misclassifying £10% of the negatives (implying a specificity rate, true negatives that will be correctly classified, of 90%) were estimated by using the rationale described by Greenhouse and Mantel (Greenhouse, S.W., & Mantel, N. (1950) Biometrics 6, 399-412) .
To demonstrate the method, it is assumed that the distributions of the method values for the positives and negatives are both normal or can be transformed to achieve normality (Figure 1) . In addition, assume that the mean and standard deviation for the positives are defined as m P and s P , and for the negatives, m N and s N , respectively, as in Figure 1 .
Given the distribution assumptions, we let the analytical value that is exceeded by 10% of the negatives be defined as N 10, which is the value corresponding to the 90th percentile of the negative distribution (i.e., N 10 = m N + 1.282s N ), and the value that is exceeded by 90% of the positives be defined as P 90 , which is the value corresponding to the 10th percentile of the positive distribution (i.e., P 90 = m P -1.282s P ); then the hypothesis to be tested is that H 0 : (N 10 £ P 90 ). If this hypothesis is false, the method is not acceptable. Note that 1.282 and -1.282 in the expressions for N 10 and P 90 , respectively, correspond to z-values for the 10 and 90% points of the normal distribution. Letting D = P 90 -N 10 , the hypothesis of interest is given as:
The sample estimates for the specified parameters are:
with the assumption that all parameter estimates are independent, is:
where n P and n N are the sample sizes for the numbers of positive and negative test samples. This sample variance ë $ V( $ D)û is estimated as:
The test statistic that may be used to test the 1-sided hypothesis (D ³ 0) is defined as:
The critical values for z are -0.84 or -1.282 for the 20 or 10% significance level, respectively.
Sample Size Estimates
The null hypothesis for the test was specified as $ D ³ 0. Assume that if the method is capable of detecting only 80% of the positives (i.e., an 80% sensitivity rate), while having a false positive rate of 10% (analogous to a specificity rate of 90%), we want to be ³80% certain of rejecting the hypothesis. As before, define P 80 as the value corresponding to the 20th percentile of the positive distribution or the value that is exceeded by 80% of the positives. If this alternative hypothesis is true, P 80 = N 10 , the expected value for $ D is P 90 -N 10 = P 90 -P 80 = -0.44s P and not zero. However, the true value for $ D will be less than its expected value plus 0.84s$ D 80% of the time. Therefore, to be 80% confident that the hypothesis P 90 = N 10 will be rejected, when in fact the alternative hypothesis (P 80 = N 10 ) is true, it is necessary for -0.44s P + 0.84s$ D to be significantly negative or £ -0.84s$ D . This inequality may be expressed as follows: 
For a given value of K, values of n P and n N that satisfy the above equation will reject the hypothesis D ³ 0, 80% of the time when D = -0.44s P . To minimize the sampling cost in validating the method, we minimize the total sample size (n P + n N ), while keeping To obtain the proper sample size, as shown in Table 1 , one needs a pilot or preliminary estimate of the variation (s P 2 and s N 2 ) of the test samples for the materials (i.e., negatives and positives) under study.
To be 90% confident that the hypothesis P 90 = N 10 will be rejected, when in fact the alternative hypothesis (P 80 = N 10 ) is true, it is necessary for -0.44s P + 1.282s$ D to be significantly negative or £ -1.282s$ D . In which case 
The technique described above was used to arrive at the appropriate sample size for a specified Table 2 , one needs a pilot or preliminary estimate of the variation (s P 2 and s N 2 ) of the test samples for the materials (i.e., negatives and positives) under study.
For validating a method with a sensitivity of 90% and false positive rate of 10%, we want to minimize T = n p + n N while keeping Sample size estimate for a specified K 
